Anna Maria Pirttilä,Janne Koskimäki,Sampo Mattila,Marena Kajula,Juho Hokkanen,Bruce Campbell
申请号:
US15327395
公开号:
US10137102B2
申请日:
2015.07.21
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to medicaments based on oligomeric forms of 3-hydroxybutyrate, particularly 3-hydroxybutyrate methyl ester dimer (1) and trimer (2), especially for use in treating, preventing and/or inhibiting development of a disorder or condition related to oxidative stress. The present invention relates also to the use of these molecules as antioxidants, and to a method for increasing proliferation and viability of plant cells in the aid of molecules 1 and 2.